Capital Management Corp VA Sells 118,345 Shares of LifeVantage Co. (NASDAQ:LFVN)

Capital Management Corp VA trimmed its holdings in LifeVantage Co. (NASDAQ:LFVN - Free Report) by 28.2% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 301,585 shares of the company's stock after selling 118,345 shares during the quarter. Capital Management Corp VA owned about 2.41% of LifeVantage worth $5,287,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also added to or reduced their stakes in the stock. Copeland Capital Management LLC bought a new position in shares of LifeVantage in the fourth quarter worth about $65,000. Barclays PLC increased its holdings in shares of LifeVantage by 38.2% in the third quarter. Barclays PLC now owns 41,966 shares of the company's stock valued at $507,000 after purchasing an additional 11,608 shares in the last quarter. Ritholtz Wealth Management raised its position in LifeVantage by 65.2% in the 4th quarter. Ritholtz Wealth Management now owns 47,348 shares of the company's stock worth $830,000 after purchasing an additional 18,682 shares during the last quarter. HighTower Advisors LLC acquired a new position in LifeVantage during the 3rd quarter worth $638,000. Finally, Bank of New York Mellon Corp boosted its position in LifeVantage by 43.9% in the 4th quarter. Bank of New York Mellon Corp now owns 74,183 shares of the company's stock valued at $1,300,000 after buying an additional 22,620 shares during the last quarter. Institutional investors and hedge funds own 35.32% of the company's stock.

Insider Buying and Selling

In other LifeVantage news, Director Raymond B. Greer sold 8,000 shares of the stock in a transaction on Monday, February 10th. The shares were sold at an average price of $20.15, for a total value of $161,200.00. Following the sale, the director now directly owns 99,288 shares in the company, valued at approximately $2,000,653.20. This trade represents a 7.46 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. 20.65% of the stock is owned by insiders.

Remove Ads

Wall Street Analysts Forecast Growth

Several equities analysts have recently issued reports on the company. Lake Street Capital started coverage on LifeVantage in a research note on Thursday, December 19th. They set a "buy" rating and a $26.00 price target on the stock. Craig Hallum assumed coverage on shares of LifeVantage in a research report on Tuesday, January 14th. They set a "buy" rating and a $35.00 target price on the stock.

LifeVantage Stock Performance

LFVN traded up $0.69 during trading on Wednesday, reaching $16.39. 235,796 shares of the company's stock were exchanged, compared to its average volume of 277,406. The company's fifty day moving average price is $19.85 and its 200-day moving average price is $15.34. The firm has a market capitalization of $205.71 million, a PE ratio of 29.27 and a beta of 0.74. LifeVantage Co. has a fifty-two week low of $5.22 and a fifty-two week high of $27.38.

LifeVantage (NASDAQ:LFVN - Get Free Report) last announced its quarterly earnings data on Wednesday, February 5th. The company reported $0.22 EPS for the quarter, topping analysts' consensus estimates of $0.14 by $0.08. LifeVantage had a return on equity of 34.29% and a net margin of 3.46%.

LifeVantage Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Monday, March 17th. Investors of record on Monday, March 3rd will be given a $0.04 dividend. The ex-dividend date is Monday, March 3rd. This represents a $0.16 dividend on an annualized basis and a dividend yield of 0.98%. LifeVantage's dividend payout ratio is 28.57%.

LifeVantage Company Profile

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.